Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
- PMID: 39915957
- PMCID: PMC11803757
- DOI: 10.1177/15347354251314529
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
Abstract
Background: With an increasing number of non-small cell lung cancer (NSCLC) patients being offered surgical treatment, postoperative rehabilitation is also being increasingly emphasized. Traditional Chinese medicine (TCM) holds promise for enhancing postoperative recovery, with treatment methods still in refinement. This study aims to evaluate the efficacy of Chinese herbal decoction and Liuzijue exercises in NSCLC patients during the rapid postoperative recovery period.
Methods: A randomized, parallel-group clinical trial assigned 50 patients to receive Chinese herbal medicine and Liuzijue exercise plus symptomatic treatment, and 49 to symptomatic treatment alone. Treatment continued until postoperative complications resolved, chest tubes were removed, and no abnormal examination findings were reported. The primary outcome was Quality of Life Questionnare-Core 30 (QLQ-C30) score. Secondary outcomes included MOS item short form 36-Item Short Form Health Survey (SF-36) score, rate of complications, six-minute walk test (6MWT) distance, Leicester Cough Questionnaire (LCQ) score, numerical rating scale (NRS) score, and functional activity score (FAS).
Results: Significant improvements in role (MD: 12.15, 95%CI: 2.99-21.32, P < .05) and social functioning (MD: 10.25, 95%CI: 1.72-18.78, P < .05) were observed in the intervention group vs. controls, as measured by QLQ-C30. The intervention group showed better post-treatment SF-36 scores in Role-Physical (RP), Social Function (SF), Role-Emotional (RE), and Mental Health Summary (MCS) (P < .05). The complication rate was lower in the intervention (20.00%) than the control group (44.44%) (P < .05). The intervention group also had a significant increase in FAS scores (P < .05) and covered a better 6MWT distance (P < .05).
Conclusion: Chinese herbal decoction and Liuzijue exercises during the rapid recovery period after lung cancer surgery enhanced patients' QoL and physical endurance, and mitigated complications.Trial registration: This tial was registered with chictr.org.cn (Registration number:ChiCTR2100044776).
Keywords: 6MWT; lung cancer; postoperative complication; quality of life; rehabilitation.
Conflict of interest statement
Declaration of Conflicting InterestsThe author (s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Preoperative exercise training for patients with non-small cell lung cancer.Cochrane Database Syst Rev. 2017 Jun 7;6(6):CD012020. doi: 10.1002/14651858.CD012020.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 Sep 28;9:CD012020. doi: 10.1002/14651858.CD012020.pub3. PMID: 28589547 Free PMC article. Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Yoga for chronic non-specific low back pain.Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010671. doi: 10.1002/14651858.CD010671.pub3. Cochrane Database Syst Rev. 2022. PMID: 36398843 Free PMC article.
-
Exercise for intermittent claudication.Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4. Cochrane Database Syst Rev. 2017. PMID: 29278423 Free PMC article.
-
Digital Therapeutics-Based Cardio-Oncology Rehabilitation for Lung Cancer Survivors: Randomized Controlled Trial.JMIR Mhealth Uhealth. 2025 Feb 25;13:e60115. doi: 10.2196/60115. JMIR Mhealth Uhealth. 2025. PMID: 39999435 Free PMC article. Clinical Trial.
Cited by
-
Integrating Traditional Chinese Medicine in Postoperative Rehabilitation for NSCLC: Advancing Evidence-Based Practices.Integr Cancer Ther. 2025 Jan-Dec;24:15347354251329897. doi: 10.1177/15347354251329897. Epub 2025 Mar 27. Integr Cancer Ther. 2025. PMID: 40145668 Free PMC article. No abstract available.
References
-
- Zhen-bin Q, Xue-ning Y, Wen-zhao Z, Yi-long W. 2020Research advances in lung cancer. J Evi-based Med. 2021;21 (01):26-30+40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous